Presternal butterfly keloid management remains a clinical challenge. This case indicates, with hypo fractionated external beam electron therapy a significant symptomatic and cosmetic benefit may be achieved without any unacceptable acute, chronic or long term toxicity.
Patient
With 15 years prior history of varicella attack, a 31-year Hispanic Venezuelan healthy male, presented in January 2011. He had several satellite keloids surrounding the central major lesion, all being developed in a post varicella scar in the anterior chest wall. Since then he has been through three surgical excisions and on each occasion the lesion recurred with worsening size and symptoms. His last resection was carried out in June 2010. By the end of 2010 he recurred again with further worsening symptom and progressive lesion. He was not considered for further resection and was referred for radiotherapy.
He was seen in radiotherapy in January 2011. He presented with a large mid presternal butterfly keloid measuring 8.5 cm × 4 -6 cm. Surrounded by 5 satellite keloids 0.5 -0.75 × 0.75 -1.5 cm. The lesions were pink, tender, hard nodular, fibrotic, criss-crossing with hard fibrotic bands especially in the main lesion. Height varied between 3 -10 mm. The total skin area that encompasses the main and satellite lesions is 9.5 × 9.5 cm 2 . Aside his progressive symptoms of severe pain and itching not controlled by medications and topical applications; unsightly appearance restricting his social interaction and personal embarrassment has led to depression and voluntary isolation.
There was no other keloid or hypertrophic scar in hisbody, did not give any specific history of allergy or atopic condition. He was not diabetic, nor had any keloid formers in the family. He did not have any African or south east Asian genetic heritage as far he knows.
Keloids arising in varicella scar are particularly resistant to available treatments [1] . Presternal butterfly keloids respond poorly to conventional radiotherapy or other form of supportive treatments. Multiple surgical resections make the keloid size bigger more fibrotic and hypoxic [2] . Hence this particular lesion had all the risk factors against achieving any reasonable result from conventional radiotherapy or combinations of modalities [3, 4] . So it was decided to treat him with Hypo fractionated external beam radiotherapy [5] primarily for symptomatic relief and secondarily for cosmesis by achieving some degree of size reduction and flattening of the lesion/s. For measurement of reaction and response, clinical photographs were taken, before, during, after each fraction and frequently during follow up to 12 months.
Radiotherapy Planning and Prescription
Anticipated risk of treating presternal region with megavoltage radiotherapy is the radiation dosage to the heart and other mediastinal structures. Hence it was decided to check the dosimetry with CT scans for Radiotherapy dosimetry using appropriate Electron Beams. Electron beam was chosen to reduce medistinal radiation and achieve better cosmesis [5, 6] . Cosmesis is a major concern in this patient.
6 MeV Electron beam, using a 15 × 15 cm 2 field with lead cut out for an area of 11.5 × 11.5 cm 2 was prepared. Since the maximum height of the lesion is approximately 10 mm thick; a 0.5-mm wax bolus was added on the surface of lesion (Figures 1(a) and (b) ).
In absence of CT scan of the chest of this patient; instead of using a phantom, we chose to use a CT scan of a male of comparable age, ethnicity, BMI and chest dimensions etc., to work out the dosimetry. A CT scan of the chest both transverse and longitudinal section was used to verify the likely depth dose and dosage to the critical mediastinal structures (Figures 1(c) and (d) ). Thus The cardiac dose will range from 250 -300 cGy over a period of 4 weeks or 28 days.
Depth dose to the mediastinum are displayed both in transverse and sagittal plane at the mid-level of the central lesion.
Tolerance and Response to Hypo Fractionated Radiotherapy
Patient tolerated the treatment well. Just after the first fraction, he experienced some alleviation of his symptom. 
Comments
Presternal butterfly keloids are very difficult to treat. Symptomatic relief with standard external beam radiotherapy may be achieved to some extent, but reduction of keloid bulk happens rarely, specially of the presternal keloids, keloids arising in varicella scars [7] and one's had multiple surgical resections [2] tends to respond poorly to any form of treatment. Intra-lesional injections of medications, compression with or without silicone gel sheets, radiotherapy of any form, fares with very limited success [3, 4] . This lesion is a clinical challenge having several poor prognostic indicators and little documented record reporting management of such a lesion. Using combinations of concurrent multi-modality treatment, Malaker et al. [8] in a series of 71 cases of recurrent or "difficult to treat keloids" reported some success. But in their series of 71 cases, 5 presternal butterfly keloids, none had multiple poor prognostic indicators like thiscase. They injected the entire lesion with combination of triamcinolone, dexamethasone and hyaluronidase, weekly for 6 -8 weeks. Immediately after the injection the lesions were covered with silicone gel sheets and compressed with 1.5 -2 cm thick hard bee wax blocks customized to the shape of the keloid, and compressed and retained with elastoplast bandage, for one week and repeat the procedure weekly [9] [10] [11] . It is cheap and suitable for, children, adolescence and women. But the intra lesional injections are painful and 6 -8 weeks of elastoplast compression is some challenge to patients for their comfort and tolerance. No other specific reports available particularly were focusing on the management of presternal keloids. But general consensus is that these are very difficult lesions to treat or to achieve any meaningful palliation. This particular case indicatesbutterfly presternal keloids may be treated with hypo fractionate delectron external beam therapy, to achieve meaningful symptomatic and cosmetic benefit. This patient will continue to improve from cosmetic point of view for next few years, with further regression and flattening of all the lesions.
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